Delivery Order SPE2DB24D2212-SPE2DB24FHNDX
Award Date
7/31/24
Potential Completion Date
8/1/24
Potential Value
$4.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $15,182.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, and has an ultimate completion date of January 16, 2025. The contract is a Delivery Order under a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating open...
This federal contract award, valued at $3,797.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, with a completion date of May 31, 2024. This contract appears to be a delivery order and is not associated with a set-aside designation, indicating open competition. AmerisourceBergen also holds a...
This federal contract award, valued at $4,524.61, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, with an ultimate completion date of March 8, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. No set-aside designation was used for this award. AmerisourceBergen Drug Corp...
This federal contract award, valued at $3,855.89, was granted to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of the pharmaceutical product CONTRAVE ER 8-90 MG TABLET 120S. This is a firm fixed price delivery order contract with a completion date of July 16, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a large...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $1,534.21 fixed-price contract is for the supply of 4565220299 CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of July 23, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) to...
This federal contract award, valued at $13,173.94, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of November 24, 2023 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this award. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,216.00 Delivery Order contract is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of December 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award, valued at $17,760.33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, with a completion date of June 11, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,770.94 firm fixed-price delivery order contract is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of May 31, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,557.67 firm fixed-price delivery order is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of January 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...